SCHEMBL5090872

SCHEMBL5090872

NN(C(=O)OCc1ccccc1)c1ccc(OCc2ccc(F)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.53
MAOB P27338 6/20 0.52
PARP10 Q53GL7 2/20 0.52
GPR34 Q9UPC5 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
LMNA P02545 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
LTA4H P09960 1/20 0.48
LAP3 P28838 1/20 0.48
ALDH1A1 P00352 1/20 0.48
RECQL P46063 1/20 0.48
MMP1 P03956 1/20 0.47
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47
MMP13 P45452 1/20 0.47
PPARA Q07869 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
ALOX5 P09917 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5090285 0.86 MAOB (0.46) NR4A2MAOBPARP10MEN1KMT2A
SCHEMBL5090818 0.86 MAOB (0.53) NR4A2MAOBPARP10LMNAALDH1A1
SCHEMBL5096558 0.85 MAOB (0.52) NR4A2MAOBPARP10MMP2MMP9
SCHEMBL5089208 0.84 MAOB (0.51) NR4A2MAOBPARP10MMP2MMP9
SCHEMBL5090749 0.84 MAOB (0.51) NR4A2MAOBPARP10MMP2MMP9
SCHEMBL5089215 0.84 MAOB (0.51) NR4A2MAOBPARP10MMP2MMP9
SCHEMBL12240751 0.84 ALDH1A1 (0.52) KMT2ALMNAALDH1A1
SCHEMBL5090322 0.83 L3MBTL1 (0.56) NR4A2MAOBPARP10LMNAALDH1A1
SCHEMBL5090765 0.83 MAOB (0.56) NR4A2MAOBPARP10ALDH1A1MMP2
SCHEMBL5087385 0.83 MAOB (0.50) NR4A2MAOBPARP10MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US claimed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 NR4A2 851/4885MAOB 808/4885PARP10 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.